These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34696960)

  • 41. Comparative study on metabolite level in tissue-specific human mesenchymal stem cells by an ultra-performance liquid chromatography quadrupole time of flight mass spectrometry.
    Lee SJ; Yi T; Ahn SH; Lim DK; Kim SN; Lee HJ; Cho YK; Lim JY; Sung JH; Yun JH; Lim J; Song SU; Kwon SW
    Anal Chim Acta; 2018 Sep; 1024():112-122. PubMed ID: 29776537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.
    Prasanna SJ; Gopalakrishnan D; Shankar SR; Vasandan AB
    PLoS One; 2010 Feb; 5(2):e9016. PubMed ID: 20126406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].
    Li F; Lyu J; Duan Y; Sun Y; Li D; Wang Y; Hu X; Xiao D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):891-6. PubMed ID: 25339324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation.
    Calle A; Barrajón-Masa C; Gómez-Fidalgo E; Martín-Lluch M; Cruz-Vigo P; Sánchez-Sánchez R; Ramírez MÁ
    Stem Cell Res Ther; 2018 Jul; 9(1):178. PubMed ID: 29973295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
    Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
    Front Immunol; 2020; 11():826. PubMed ID: 32435248
    [No Abstract]   [Full Text] [Related]  

  • 46. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
    Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
    Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor.
    Diederichs S; Tuan RS
    Stem Cells Dev; 2014 Jul; 23(14):1594-610. PubMed ID: 24625206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of Donor's Age on Immunomodulatory Properties of Canine Adipose Tissue-Derived Mesenchymal Stem Cells.
    Taguchi T; Borjesson DL; Osmond C; Griffon DJ
    Stem Cells Dev; 2019 Dec; 28(23):1562-1571. PubMed ID: 31588862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and Therapeutic Application of Mesenchymal Stem Cells with Neuromesodermal Origin from Human Pluripotent Stem Cells.
    Wang H; Li D; Zhai Z; Zhang X; Huang W; Chen X; Huang L; Liu H; Sun J; Zou Z; Fan Y; Ke Q; Lai X; Wang T; Li X; Shen H; Xiang AP; Li W
    Theranostics; 2019; 9(6):1683-1697. PubMed ID: 31037131
    [No Abstract]   [Full Text] [Related]  

  • 50. Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells.
    Lo Surdo J; Bauer SR
    Tissue Eng Part C Methods; 2012 Nov; 18(11):877-89. PubMed ID: 22563812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro.
    Connard SS; Linardi RL; Even KM; Berglund AK; Schnabel LV; Ortved KF
    Vet Immunol Immunopathol; 2021 Apr; 234():110203. PubMed ID: 33636546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Predictive Gene Markers for Multipotent Stromal Cell Proliferation.
    Bellayr IH; Marklein RA; Lo Surdo JL; Bauer SR; Puri RK
    Stem Cells Dev; 2016 Jun; 25(11):861-73. PubMed ID: 27036644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.
    Fu X; Chen Y; Xie FN; Dong P; Liu WB; Cao Y; Zhang WJ; Xiao R
    Tissue Eng Part A; 2015 Feb; 21(3-4):616-26. PubMed ID: 25256849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
    Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
    Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.
    Kim J; Breunig MJ; Escalante LE; Bhatia N; Denu RA; Dollar BA; Stein AP; Hanson SE; Naderi N; Radek J; Haughy D; Bloom DD; Assadi-Porter FM; Hematti P
    Cytotherapy; 2012 Sep; 14(8):925-35. PubMed ID: 22571381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.
    Salem B; Miner S; Hensel NF; Battiwalla M; Keyvanfar K; Stroncek DF; Gee AP; Hanley PJ; Bollard CM; Ito S; Barrett AJ
    Cytotherapy; 2015 Dec; 17(12):1675-86. PubMed ID: 26422657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene markers of cellular aging in human multipotent stromal cells in culture.
    Bellayr IH; Catalano JG; Lababidi S; Yang AX; Lo Surdo JL; Bauer SR; Puri RK
    Stem Cell Res Ther; 2014 Apr; 5(2):59. PubMed ID: 24780490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Canine placenta: A promising potential source of highly proliferative and immunomodulatory mesenchymal stromal cells?
    Saulnier N; Loriau J; Febre M; Robert C; Rakic R; Bonte T; Buff S; Maddens S
    Vet Immunol Immunopathol; 2016 Mar; 171():47-55. PubMed ID: 26964717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production.
    Trivedi A; Miyazawa B; Gibb S; Valanoski K; Vivona L; Lin M; Potter D; Stone M; Norris PJ; Murphy J; Smith S; Schreiber M; Pati S
    J Transl Med; 2019 Apr; 17(1):128. PubMed ID: 30995929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.